GTS Securities’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $423K | Buy |
806
+87
| +12% | +$45.7K | 0.02% | 731 |
|
|
2025
Q1 | $456K | Sell |
719
-628
| -47% | -$398K | 0.02% | 734 |
|
|
2024
Q4 | $960K | Sell |
1,347
-3,047
| -69% | -$2.17M | 0.05% | 343 |
|
|
2024
Q3 | $4.62M | Sell |
4,394
-3,345
| -43% | -$3.52M | 0.01% | 199 |
|
|
2024
Q2 | $8.13M | Buy |
7,739
+4,184
| +118% | +$4.4M | 0.02% | 105 |
|
|
2024
Q1 | $3.42M | Sell |
3,555
-183
| -5% | -$176K | 0.01% | 227 |
|
|
2023
Q4 | $3.28M | Buy |
3,738
+3,143
| +528% | +$2.76M | 0.01% | 264 |
|
|
2023
Q3 | $490K | Buy |
+595
| New | +$490K | ﹤0.01% | 795 |
|